In recent years, the use of advanced magnetic resonance (MR) imaging methods such as functional magnetic resonance imaging (fMRI) and structural magnetic resonance imaging (sMRI) has recorded a great increase in neuropsychiatric disorders. Deep learning is a branch of machine learning that is increasingly being used for applications of medical image analysis such as computer-aided diagnosis. In a bid to classify and represent learning tasks, this study utilized one of the most powerful deep learning algorithms (deep belief network (DBN)) for the combination of data from Autism Brain Imaging Data Exchange I and II (ABIDE I and ABIDE II) datasets. The DBN was employed so as to focus on the combination of resting-state fMRI (rs-fMRI), gray matter (GM), and white matter (WM) data. This was done based on the brain regions that were defined using the automated anatomical labeling (AAL), in order to classify autism spectrum disorders (ASDs) from typical controls (TCs). Since the diagnosis of ASD is much more effective at an early age, only 185 individuals (116 ASD and 69 TC) ranging in age from 5 to 10 years were included in this analysis. In contrast, the proposed method is used to exploit the latent or abstract high-level features inside rs-fMRI and sMRI data while the old methods consider only the simple low-level features extracted from neuroimages. Moreover, combining multiple data types and increasing the depth of DBN can improve classification accuracy. In this study, the best combination comprised rs-fMRI, GM, and WM for DBN of depth 3 with 65.56% accuracy (sensitivity = 84%, specificity = 32.96%, F1 score = 74.76%) obtained via 10-fold cross-validation. This result outperforms previously presented methods on ABIDE I dataset.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.